a drug called olaparib prevents the repair of dna single-strand breaks (ssb); following dna replication, ssb could lead to accumulation of dna double-strand breaks (dsb). inhibition of both ssb and dsb repair in a cell is typically lethal. what is the rationale for using a drug that causes increased dna damage to treat brca1-mutant breast cancer? group of answer choices